Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Items for the Week Previous | All Articles This Week | Next
This article originally posted and appeared in  CardiovascularBG ControlIssue 730

High-normal A1c Signals CAD Risk in Nondiabetic Patients

Among patients who don't have diabetes, high-normal HbA1c levels (at or above 5.8%) are strongly correlated with the risk of coronary artery disease.... 

Advertisement

In what they described as the first large-scale study to assess the relationships among HbA1c, CAD, and carotid intima-medial thickness, researchers enrolled 1,703 consecutive patients undergoing either elective or urgent coronary angiography at a single medical center during a 5-year period. These nondiabetic patients were divided into tertiles according to their HbA1c levels: low (less than 5.5%), intermediate (5.5%-5.79%), or high (5.8% or higher), reported Dr. Monica Verdoia of the cardiology department, Maggiore della Carita Hospital, Novara (Italy), and her associates.

HbA1c was significantly associated in a dose-dependent fashion with the prevalence of CAD on angiography (odds ratio, 1.33). CAD prevalence was 66.9% in patients who had low-normal HbA1c, 73.7% in those with intermediate HbA1c, and 78.6% in those with high-normal HbA1c. This association remained robust after the data were adjusted to account for many confounding factors, including patient age and sex; the presence or absence of hypertension, hypercholesterolemia, renal failure, and previous myocardial infarction; and the use or nonuse of medications including angiotensin receptor blockers, beta-blockers, nitrates, statins, or diuretics, the investigators said.

This strong association between high-normal HbA1c and CAD prevalence persisted across every high-risk subgroup that was assessed. HbA1c also was independently and strongly associated with carotid intima-medial thickness and the prevalence of carotid plaques on ultrasonography.

The best cutoff value for predicting the presence of significant CAD was determined to be 5.8%. Even though this level is within the normal range, it "should be regarded as a risk factor for atherosclerosis," Dr. Verdoia and her associates said.

Further research is needed to confirm these findings and to assess whether more aggressive preventive strategies, such as lifestyle changes, the use of statins, or antiplatelet therapies, might reduce the development and progression of atherosclerosis in such patients, they added.

Practice Pearls:
  • The prevalence of CAD was 66.9% in nondiabetic patients who had low-normal HbA1c, 73.7% in those with intermediate HbA1c, and 78.6% in those with high-normal HbA1c.
  • A1c levels (at or above 5.8%) are strongly correlated with the risk of coronary artery disease

Am. J. Prev. Med. 2014 April 21 [doi: 10.1016/j.amepre.2014.02.002]).  

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 23 May, 2014 and appeared in  CardiovascularBG ControlIssue 730

Past five issues: Issue 796 | Diabetes Clinical Mastery Series Issue 255 | Issue 795 | SGLT-2 Inhibitors Special Edition August 2015 | Diabetes Clinical Mastery Series Issue 254 |

2015 Most Popular Articles:

Coffee Consumption Proves Potential in Reducing Type 2 Diabetes Risk
Posted August 07, 2015
Impaired Glucose Uptake in the Brain May Increase Alzheimer's Disease Risk
Posted August 07, 2015
First Non-Surgical Weight Loss Procedure for Mild-to-Moderate Obesity
Posted August 07, 2015
GLP-1 Agonist Semaglutide Completes Phase III Trial with Positive Results
Posted August 07, 2015
Ketoacidosis Not as Great as Thought in Diabetes Patients Taking Invokana
Posted August 13, 2015
Impact of Switching Insulin Glargine to Insulin Detemir in T2 Patients
Posted August 14, 2015
SIgnificant Weight Gain Associated with Laparoscopic Sleeve Gastrectomy
Posted August 14, 2015
Two New Possible Methods for Diagnosing and Monitoring Diabetes
Posted August 07, 2015
Diabetes Combination Drug LixiLan Meets Main Target in Late Stage Trial
Posted August 07, 2015
Soybean Oil Causes More Obesity and Diabetes Than Fructose
Posted August 20, 2015


Browse by Feature Writer & Article Category.
A. Lee Dellon, MD | Aaron I. Vinik, MD, PhD, FCP, MACP | Beverly Price | Charles W Martin, DD | Derek Lowe, PhD | Dr. Brian Jakes, Jr. | Dr. Fred Pescatore | Dr. Tom Burke, Ph.D | Eric S. Freedland | Evan D. Rosen | Ginger Kanzer-Lewis | Greg Milliger | Kristina Sandstedt | Laura Plunkett | Leonard Lipson, M.A. | Louis H. Philipson | Maria Emanuel Ryan, DDS, PhD | Marilyn Porter, RD, CDE | Melissa Diane Smith | Michael R. Cohen, RPh, MS, ScD, FASHP | Paul Chous, M.A., OD | Philip A. Wood PhD | R. Keith Campbell, Professor, B.Pharm, MBA, CDE | Richard K. Bernstein, MD | Sheri R. Colberg PhD | Sherri Shafer | Stanley Schwartz, MD, FACP, FACE | Steve Pohlit | Steven V. Edelman, M.D. | Timothy S. Hollingshead |

Cast Your Vote
What percentage of your patients have reached goal for A1c, BP and cholesterol?

CME/CE of the Week
Marie Williams, DPM

Category: Wound Care
Credits: .75